| Year |
Citation |
Score |
| 2022 |
Azevedo C, Teku G, Pomeshchik Y, Reyes JF, Chumarina M, Russ K, Savchenko E, Hammarberg A, Lamas NJ, Collin A, Gouras GK, Klementieva O, Hallbeck M, Taipa R, Vihinen M, et al. Parkinson's disease and multiple system atrophy patient iPSC-derived oligodendrocytes exhibit alpha-synuclein-induced changes in maturation and immune reactive properties. Proceedings of the National Academy of Sciences of the United States of America. 119: e2111405119. PMID 35294277 DOI: 10.1073/pnas.2111405119 |
0.706 |
|
| 2021 |
Russ K, Teku G, Bousset L, Redeker V, Piel S, Savchenko E, Pomeshchik Y, Savistchenko J, Stummann TC, Azevedo C, Collin A, Goldwurm S, Fog K, Elmer E, Vihinen M, et al. TNF-α and α-synuclein fibrils differently regulate human astrocyte immune reactivity and impair mitochondrial respiration. Cell Reports. 34: 108895. PMID 33761362 DOI: 10.1016/j.celrep.2021.108895 |
0.756 |
|
| 2020 |
Azevedo C, Chumarina M, Serafimova E, Goldwurm S, Collin A, Roybon L, Savchenko E, Pomeshchik Y. Generation of an induced pluripotent stem cell line (CSC-32) from a patient with Parkinson's disease carrying a heterozygous variation p.A53T in the SNCA gene. Stem Cell Research. 43: 101694. PMID 31954327 DOI: 10.1016/J.Scr.2019.101694 |
0.778 |
|
| 2019 |
Chumarina M, Russ K, Azevedo C, Heuer A, Pihl M, Collin A, Frostner EÅ, Elmer E, Hyttel P, Cappelletti G, Zini M, Goldwurm S, Roybon L. Cellular alterations identified in pluripotent stem cell-derived midbrain spheroids generated from a female patient with progressive external ophthalmoplegia and parkinsonism who carries a novel variation (p.Q811R) in the POLG1 gene. Acta Neuropathologica Communications. 7: 208. PMID 31843010 DOI: 10.1186/S40478-019-0863-7 |
0.778 |
|
| 2019 |
Bogetofte H, Jensen P, Ryding M, Schmidt SI, Okarmus J, Ritter L, Worm CS, Hohnholt MC, Azevedo C, Roybon L, Bak LK, Waagepetersen H, Ryan BJ, Wade-Martins R, Larsen MR, et al. Mutation Causes Metabolic Disturbances and Impaired Survival of Human iPSC-Derived Neurons. Frontiers in Cellular Neuroscience. 13: 297. PMID 31333417 DOI: 10.3389/Fncel.2019.00297 |
0.723 |
|
| 2018 |
Gustavsson N, Marote A, Pomeshchik Y, Russ K, Azevedo C, Chumarina M, Goldwurm S, Collin A, Pinto L, Salgado AJ, Klementieva O, Roybon L, Savchenko E. Generation of an induced pluripotent stem cell line (CSC-46) from a patient with Parkinson's disease carrying a novel p.R301C mutation in the GBA gene. Stem Cell Research. 34: 101373. PMID 30640063 DOI: 10.1016/J.Scr.2018.101373 |
0.741 |
|
| 2017 |
Chumarina M, Azevedo C, Bigarreau J, Vignon C, Kim KS, Li JY, Roybon L. Derivation of mouse embryonic stem cell lines from tyrosine hydroxylase reporter mice crossed with a human SNCA transgenic mouse model of Parkinson's disease. Stem Cell Research. 19: 17-20. PMID 28413000 DOI: 10.1016/J.Scr.2016.12.026 |
0.768 |
|
| 2017 |
Djelloul M, Azevedo C, Pomeshchik Y, Hammarberg A, Roybon L. Reporting on methods to generate and purify rodent and human oligodendrocytes from different sources. Stem Cell Research. 20: 58-66. PMID 28395742 DOI: 10.1016/J.Scr.2017.02.008 |
0.772 |
|
| 2016 |
Holmqvist S, Lehtonen Š, Chumarina M, Puttonen KA, Azevedo C, Lebedeva O, Ruponen M, Oksanen M, Djelloul M, Collin A, Goldwurm S, Meyer M, Lagarkova M, Kiselev S, Koistinaho J, et al. Creation of a library of induced pluripotent stem cells from Parkinsonian patients. Npj Parkinson's Disease. 2: 16009. PMID 28725696 DOI: 10.1038/Npjparkd.2016.9 |
0.772 |
|
| 2015 |
Djelloul M, Holmqvist S, Boza-Serrano A, Azevedo C, Yeung MS, Goldwurm S, Frisén J, Deierborg T, Roybon L. Alpha-Synuclein Expression in the Oligodendrocyte Lineage: an In Vitro and In Vivo Study Using Rodent and Human Models. Stem Cell Reports. 5: 174-84. PMID 26235891 DOI: 10.1016/J.Stemcr.2015.07.002 |
0.82 |
|
| Show low-probability matches. |